BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34728178)

  • 21. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
    Wang J; Xu Y; Zhao H; Zhang X
    J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody signature in hepatocellular carcinoma using seromics.
    Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q
    J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
    Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
    Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer.
    Pan J; Yu L; Wu Q; Lin X; Liu S; Hu S; Rosa C; Eichinger D; Pino I; Zhu H; Qian J; Huang Y
    Mol Cell Proteomics; 2020 Mar; 19(3):490-500. PubMed ID: 31924693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
    Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
    Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
    J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.
    Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
    Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
    Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
    Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma.
    Raedle J; Oremek G; Truschnowitsch M; Lorenz M; Roth WK; Caspary WF; Zeuzem S
    Eur J Cancer; 1998 Jul; 34(8):1198-203. PubMed ID: 9849479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC.
    Heo CK; Woo MK; Yu DY; Lee JY; Yoo JS; Yoo HS; Ko JH; Kim JM; Choi JY; Kim IG; Paik SG; Cho EW
    Int J Oncol; 2010 Jun; 36(6):1453-9. PubMed ID: 20428769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and clinical evaluation of dominant peptides of centromere protein F antigen for early diagnosis of hepatocellular carcinoma.
    Li S; Li X; Xu A; Zhang B; He X; Chen H; Huang J
    Mol Med Rep; 2018 Mar; 17(3):4720-4728. PubMed ID: 29328419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
    Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis.
    Chang Y; Liu B; Niu H; Wang Z; Xia S; Li H
    Medicine (Baltimore); 2020 Aug; 99(34):e21887. PubMed ID: 32846849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.